STTK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Shattuck Labs Inc (STTK) is not a strong buy for a beginner investor with a long-term focus at this time. The company's financial performance is weak, with significant revenue and net income declines. While analysts have mixed ratings and some potential catalysts exist, the technical indicators and options data do not suggest a strong upward trend. Additionally, there are no recent significant insider or hedge fund activities, and no congress trading data to support a buy decision.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 45.9, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 3.878, with resistance at 4.149 and support at 3.607. Overall, the technical indicators suggest a neutral to slightly bearish outlook.
Potential Phase 1 data in Q2 2026 could act as a catalyst.
EPS also fell by -57.58% YoY. No recent news or significant insider/hedge fund activity. High implied volatility (290.
suggests uncertainty.
In Q3 2025, revenue dropped by -66.63% YoY to $1,000,000. Net income fell by -39.69% YoY to -$10,056,000. EPS decreased by -57.58% YoY to -0.14. Gross margin remained stable at 100%. Overall, the financials indicate poor performance and declining growth trends.
Piper Sandler initiated coverage with an Overweight rating and a $15 price target, citing potential success of SL-325. Citi raised its price target to $4 from $2 but maintained a Neutral rating, reflecting mixed sentiment among analysts.
